Companies: 49,246 Total Market Cap: 132386205533959.40

Ibnsina Pharma

EGX-ISPH

Drugs, Drug Proprietaries, and Druggists' Sundries

Rank #20216

Market Cap 185.34 M

Volume 5.69 M

Price 0.18

Change (%) 0.21%

Country or region

Egypt

Ibnsina Pharma's latest marketcap:

185.34 M

As of 05/20/2025, Ibnsina Pharma's market capitalization has reached $185.34 M. According to our data, Ibnsina Pharma is the 20216th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	185.34 M
Revenue (ttm)	1.22 B
Net Income (ttm)	11.05 M
Shares Out	1.01 B
EPS (ttm)	0.01
Forward PE	8.49
Ex-Dividend Date	n/a
Earnings Date	05/22/2025

Market Cap Chart

Data Updated: 05/20/2025

Ibnsina Pharma's yearly market capitalization.

Ibnsina Pharma has seen its market value grow from 4.89 B EGP to 9.49 B EGP since 2020, representing a total increase of 94.12% and an annual compound growth rate (CAGR) of 16.33%.

Date	Market Cap(EGP)	Change (%)
05/20/2025	9.49 B	35.71%
12/31/2024	7.06 B	100.64%
12/31/2023	3.52 B	45.37%
12/29/2022	2.42 B	-38.08%
12/30/2021	3.91 B	-20.04%
12/31/2020	4.89 B

Company Profile

About Ibnsina Pharma

Ibnsina Pharma is a leading pharmaceutical distributor based in Egypt, specializing in the supply of pharmaceutical and cosmetic products to a diverse range of clients.

Products & Services

Distribution of pharmaceutical and cosmetic products to retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions.
Warehousing and logistics support for suppliers.
Marketing solutions tailored to client needs.
Importation, packaging, and market research services.
Value-added services to enhance customer experience.

Company Background

Founded in 2001, Ibnsina Pharma is headquartered in El Obour City, Egypt, and has established itself as a trusted partner in the pharmaceutical distribution sector.

Frequently Asked Questions

As of 05/20/2025, Ibnsina Pharma (including the parent company, if applicable) has an estimated market capitalization of $185.34 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Ibnsina Pharma global market capitalization ranking is approximately 20216 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Egypt
Founded	2001
IPO Date	n/a
Employees	5,500
CEO	Mohamed Mohsen Mahgoub
Sector
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Address	Industrial Zone 1 El Obour City Egypt
Website	https://www.ibnsina-pharma.com